Skip links

LAMZEDE® (velmanase alfa-tycv)

Full Name LAMZEDE® (velmanase alfa-tycv)
Drug LAMZEDE
Manufacturer Chiesi Farmaceutici
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients
Disease Alpha-mannosidosis
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number (800) 240-9572
Fax Number (847) 427-7976
Product Website lamzede.com/hcp